Abstract |
Three new modified peptides named grassystatins D-F (1-3) were discovered from a marine cyanobacterium from Guam. Their structures were elucidated using NMR spectroscopy and mass spectrometry. The hallmark structural feature in the peptides is a statine unit, which contributes to their aspartic protease inhibitory activity preferentially targeting cathepsins D and E. Grassystatin F (3) was the most potent analogue, with IC50 values of 50 and 0.5 nM against cathepsins D and E, respectively. The acidic tumor microenvironment is known to increase the activation of some of the lysosomal proteases associated with tumor metastasis such as cathepsins. Because cathepsin D is a biomarker in aggressive forms of breast cancer and linked to poor prognosis, the effects of cathepsin D inhibition by 1 and 3 on the downstream cellular substrates cystatin C and PAI-1 were investigated. Furthermore, the functional relevance of targeting cathepsin D substrates was evaluated by examining the effect of 1 and 3 on the migration of MDA-MD-231 cells. Grassystatin F (3) inhibited the cleavage of cystatin C and PAI-1, the activities of their downstream targets cysteine cathepsins and tPA, and the migration of the highly aggressive triple negative breast cancer cells, phenocopying the effect of siRNA-mediated knockdown of cathepsin D.
|
Authors | Fatma H Al-Awadhi, Brian K Law, Valerie J Paul, Hendrik Luesch |
Journal | Journal of natural products
(J Nat Prod)
Vol. 80
Issue 11
Pg. 2969-2986
(11 22 2017)
ISSN: 1520-6025 [Electronic] United States |
PMID | 29087712
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Amino Acids
- Peptides
- Plasminogen Activator Inhibitor 1
- Protease Inhibitors
- SERPINE1 protein, human
- grassystatin D
- grassystatin E
- grassystatin F
- Aspartic Acid Proteases
- Endopeptidases
- Cathepsin L
- Cathepsin E
- Cathepsin D
- statine
|
Topics |
- Amino Acids
- Aspartic Acid Proteases
(drug effects)
- Cathepsin D
(antagonists & inhibitors)
- Cathepsin E
(antagonists & inhibitors)
- Cathepsin L
(metabolism)
- Cyanobacteria
(chemistry)
- Dose-Response Relationship, Drug
- Endopeptidases
(metabolism)
- Female
- Guam
- Humans
- Inhibitory Concentration 50
- Lysosomes
(metabolism)
- Molecular Structure
- Nuclear Magnetic Resonance, Biomolecular
- Peptides
(chemistry, isolation & purification, pharmacology)
- Plasminogen Activator Inhibitor 1
(metabolism)
- Protease Inhibitors
(pharmacology)
|